Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The government funding status notice was removed from the page. The study details, contacts, and locations remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T15:03:52.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    No substantive changes detected between the two screenshots. Core study details such as the title, NCT number, enrollment, and locations appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:28:03.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    Major update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.
    Difference
    3%
    Check dated 2025-10-05T10:26:30.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Update: version tag changed from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:19:23.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element has been removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:35:08.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:07:10.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.